Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Disparities in late-stage pancreatic cancer: Retrospective analysis of genomic testing and outcomes between Hispanics and non-Hispanics.
Authors
Ricardo J. Estrada-Mendizabal
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico;
Ricardo J. Estrada-Mendizabal , Ritika Halder , Amith Rao , Ce Cheng , Isabellyana Dominguez , Sumana Veeravelli , Alejandro Recio-Boiles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 663)
DOI
10.1200/JCO.2023.41.4_suppl.663
Abstract #
663
Poster Bd #
H7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Targetable genomic mutations in young women with advanced breast cancer.
First Author: Norin Ansari
Poster
2021 ASCO Annual Meeting
Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer.
First Author: Evan Justin Walker
Poster
2023 ASCO Annual Meeting
A phase 3 study of gedatolisib plus fulvestrant with and without palbociclib in patients with HR+/ HER2- advanced breast cancer previously treated with a CDK4/6 inhibitor plus a nonsteroidal aromatase inhibitor (VIKTORIA-1).
First Author: Sara A. Hurvitz
Poster
2023 ASCO Annual Meeting
Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative.
First Author: Elisa Agostinetto